Arrow Greentech Announces FY26 Results, Highlights 52% Growth in Green Segment
Arrow Greentech Limited announced its performance for the fourth quarter and full year of FY26. The company reported a full-year revenue of Rs. 2,005 million, with EBITDA standing at Rs. 646 million, marking a margin of 32.2%. Profit After Tax (PAT) was recorded at Rs. 474 million, achieving a PAT margin of 22.7%.Speaking on the results, Mr. Shilpan Patel, Chairman and Managing Director, noted that the Green segment exhibited strong growth, posting a 52% Year-over-Year (YoY) increase from Rs. 243 million to Rs. 369 million. He highlighted the increasing market acceptance of the company's sustainable product offerings and expressed confidence that the opportunity landscape for environmental friendly packaging, both in India and global markets, remains robust.
Mr. Patel acknowledged that the High-tech segment experienced a recalibration period but stated that the company is actively addressing this through focused initiatives. He emphasized that the firm's long-term focus remains on sustainable and profitable growth, utilizing the year to strengthen operational foundations by enhancing cost discipline, deepening customer engagement, and investing in R&D.
Financial Performance Summary
The company’s operational highlights confirm the financial performance across the fiscal year:- Revenue from Operation (FY26): Rs. 2,005 Million.
- Green Segment Contribution: Rs. 369 million, representing 18% of revenue, up 52% YoY.
- EBITDA (FY26): Rs. 646 Millions (32.2% margin).
- PAT (FY26): Rs. 474 Millions (22.7% margin).
- Dividend: The Board of Directors declared a dividend of Rs. 5 per equity share for the financial year 2025-26.
Financial Statements Overview
The financial health of the company was detailed through its consolidated statements for the respective years.Consolidated Profit & Loss Statement (Rs. in Mn)
| Particulars | Q4FY26 | Q4FY25 | Y-o-Y | Q3FY26 | Q-o-Q | FY26 | FY25 | Y-o-Y |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 418 | 573 | 561 | 2,005 | 2,434 | |||
| Total Revenue | 418 | 573 | -27.1% | 561 | -25.5% | 2,005 | 2,434 | -17.6% |
| Gross Profit | 232 | 282 | -17.6% | 304 | -23.8% | 1,093 | 1,313 | -16.7% |
| Gross Profit Margin (%) | 55.5% | 49.1% | 54.3% | 54.5% | 54.0% | |||
| EBITDA | 104 | 160 | -35.3% | 192 | -46.0% | 646 | 884 | -26.9% |
| EBITDA Margin (%) | 24.8% | 28.0% | 34.3% | 32.2% | 36.3% | |||
| Profit After Tax | 74 | 114 | -34.7% | 133 | -44.0% | 474 | 630 | -24.8% |
| PAT Margin (%) | 16.8% | 19.3% | 22.8% | 22.7% | 25.3% |
Consolidated Balance Sheet (Rs. in Mn)
| Assets | Mar-26 | Mar-25 |
|---|---|---|
| Total Non-Current Assets | 571 | 558 |
| Total Current Assets | 1,987 | 1,526 |
| Total Assets | 2,558 | 2,084 |
| Total Equity | 2,362 | 1,900 |
| Total Non-Current Liabilities | 51 | 36 |
| Total Current Liabilities | 145 | 148 |
| Total Equity & Liabilities | 2,558 | 2,084 |
Consolidated Cashflow Statement (Rs. in Mn)
| Particulars | Mar-26 | Mar-25 |
|---|---|---|
| Net Cash from Operating Activities | 431 | 676 |
| Cash Flow from Investing Activities | -259 | -546 |
| Cash Flow from Financing Activities | -71 | -39 |
| Net increase/ (decrease) in Cash&Cashequivalent | 101 | 91 |
| Cash and cash equivalents at the end of the year | 268 | 167 |
Advanced Products and Intellectual Property
Arrow Greentech Limited maintains a strong focus on patented technologies, especially in the water-soluble film sector, and advanced pharmaceutical delivery systems.The company has achieved significant intellectual property milestones, holding 24 granted patents globally across multiple territories, including India, UK, USA, Europe, Sri Lanka, and Malaysia. Furthermore, it possesses 40 registered trademarks in India.
Key areas covered by the granted patents include:
- Paper and Packing Industry (e.g., Cold Water Soluble Film)
- Packaging Industry (e.g., Improved Water Soluble Film)
- Security Products (e.g., Security Laminates)
- Health, Hygiene & Food (e.g., Medicated Bands)
- Printing and PSA Materials
In the healthcare domain, the company utilizes its proprietary technology to develop the Mouth Dissolving Strip (MDS) platform. This patented technology enables the embedding or entrapment of multiple active ingredients for targeted, precise, and rapid oral drug delivery, supporting multiple routes like lingual, sublingual, and buccal.
The company's nutraceutical product line, marketed under FASSAI Products, includes a wide range of vitamin and wellness supplements delivered via MDS, such as VitaminB12(Cyanocobalamin)MDS and VitaminD3+K2+CalciumMDS.
For pharmaceutical applications, the Arrow RX line features various MDS and Oral Dosage Forms (ODS), including Nicotine PolacrilexMDS and AmlodipineMDS, confirming the company’s role in developing innovative drug delivery systems for both domestic and export markets.
ARROWGREEN Stock Price Movement
As of 2:41 PM, shares of Arrow Greentech Limited are slipping by 3.59% in live trading, currently resting at ₹460.1. The stock shed ₹17.15 today, with trading activity coming through an elevated volume of 130,438 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: